1-β-D-Ribofuranosyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
Modify Date: 2024-02-05 18:15:39
![1-β-D-Ribofuranosyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine Structure](https://www.chemsrc.com/caspic/069/70421-30-6.png)
1-β-D-Ribofuranosyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine structure
|
Common Name | 1-β-D-Ribofuranosyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine | ||
|---|---|---|---|---|
| CAS Number | 70421-30-6 | Molecular Weight | 282.26 | |
| Density | 2.3±0.1 g/cm3 | Boiling Point | 767.1±70.0 °C at 760 mmHg | |
| Molecular Formula | C10H14N6O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 417.7±35.7 °C | |
Use of 1-β-D-Ribofuranosyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine1-β-D-Ribofuranosyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 1-(β-D-Ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine |
|---|---|
| Synonym | More Synonyms |
| Description | 1-β-D-Ribofuranosyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 2.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 767.1±70.0 °C at 760 mmHg |
| Molecular Formula | C10H14N6O4 |
| Molecular Weight | 282.26 |
| Flash Point | 417.7±35.7 °C |
| Exact Mass | 282.107666 |
| LogP | -1.56 |
| Vapour Pressure | 0.0±2.7 mmHg at 25°C |
| Index of Refraction | 1.986 |
| 1H-Pyrazolo[3,4-d]pyrimidine-4,6-diamine, 1-β-D-ribofuranosyl- |
| 1-(β-D-Ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine |